BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2704507)

  • 1. Normal-sized ovary carcinoma syndrome.
    Feuer GA; Shevchuk M; Calanog A
    Obstet Gynecol; 1989 May; 73(5 Pt 1):786-92. PubMed ID: 2704507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Normal-sized ovary carcinoma syndrome: histopathological analysis of 14 cases].
    Yamazaki T; Hatano H; Suzuki A; Sugase M; Nakamura M; Sekiya M; Ueda N; Haba K; Tsukahara Y; Fujii S
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Jan; 47(1):27-34. PubMed ID: 7844450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Normal-sized ovary carcinoma syndrome--clinical and pathological analysis of 11 cases].
    Yao Z; Li L; Yang H
    Zhonghua Zhong Liu Za Zhi; 1998 Sep; 20(5):383-6. PubMed ID: 10921039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathological, cytological and immunohistochemical study of normal-sized ovary carcinoma syndrome].
    Takekawa Y; Kimura M; Sakakibara M; Yoshii R; Shikata T
    Rinsho Byori; 2001 Jan; 49(1):66-70. PubMed ID: 11215487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical analysis of 9 cases of the normal-sized ovary carcinoma syndrome].
    Cao LQ; Li X; Li XG
    Hunan Yi Ke Da Xue Xue Bao; 2002 Jun; 27(3):275-6. PubMed ID: 12575315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of normal-sized ovaries associated with primary peritoneal serous carcinoma for possible precursors of ovarian serous carcinoma.
    Seidman JD; Wang BG
    Gynecol Oncol; 2007 Jul; 106(1):201-6. PubMed ID: 17477958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
    Young RH
    Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of the clinical characteristics and prognostic factors with primary normal-sized epithelial ovarian carcinoma syndrome].
    Wang C; Li L; Qi X
    Zhonghua Fu Chan Ke Za Zhi; 2000 Jul; 35(7):420-2. PubMed ID: 11776190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Status of the contralateral ovary in encapsulated low grade malignant tumors of the ovary.
    Williams TJ; Dockerty MB
    Surg Gynecol Obstet; 1976 Nov; 143(5):763-6. PubMed ID: 982255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serous surface papillary carcinoma. A clinicopathologic study of 10 cases and comparison with stage III-IV ovarian serous carcinoma.
    Mills SE; Andersen WA; Fechner RE; Austin MB
    Am J Surg Pathol; 1988 Nov; 12(11):827-34. PubMed ID: 3189692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary tumor site.
    Hainsworth JD; Greco FA
    Semin Oncol; 1993 Jun; 20(3):279-86. PubMed ID: 8503024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinical and pathological characters of malignant neoplasms arising from endometriosis].
    Jiang QC
    Zhonghua Fu Chan Ke Za Zhi; 1993 Jun; 28(6):340-2, 380-1. PubMed ID: 8243157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mistaken diagnosis of carcinoma of the ovary.
    McGowan L; Norris HJ
    Surg Gynecol Obstet; 1991 Sep; 173(3):211-5. PubMed ID: 1925882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
    Veras E; Deavers MT; Silva EG; Malpica A
    Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical behavior of serous and mucinous borderline tumors of the ovary with diploid DNA stem line. Follow-up studies after organ preserving and non-organ preserving therapy].
    Mecke H; Börner-Klaussner B; Grosse G; Nadjari B; Hauptmann S
    Zentralbl Gynakol; 2000; 122(5):274-9. PubMed ID: 10857214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cul-de-sac aspiration cytology in the management and follow-up of patients with ovarian carcinoma. A preliminary report.
    Goldberg G; Learmonth G; Bloch B; Levin W
    J Reprod Med; 1985 Nov; 30(11):867-70. PubMed ID: 4078821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary peritoneal serous papillary carcinoma: a study of 25 cases and comparison with stage III-IV ovarian papillary serous carcinoma.
    Ben-Baruch G; Sivan E; Moran O; Rizel S; Menczer J; Seidman DS
    Gynecol Oncol; 1996 Mar; 60(3):393-6. PubMed ID: 8774644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries.
    Ayhan A; Guvenal T; Salman MC; Ozyuncu O; Sakinci M; Basaran M
    Gynecol Oncol; 2005 Aug; 98(2):235-41. PubMed ID: 15982725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary.
    Comin CE; Saieva C; Messerini L
    Am J Surg Pathol; 2007 Aug; 31(8):1139-48. PubMed ID: 17667535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.